Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Disorders

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...

Bone Remodeling

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.

Osteoclasts in Bone Remodeling

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Spatial and temporal associations between animal ownership and malaria prevalence in Africa using cross-sectional national Demographic and Health Surveys.

One health (Amsterdam, Netherlands)·2026

Same author

Impact of 18-FDG PET-CT on the preoperative staging and management of Incidental Gall Bladder Cancer (IGBC)- A prospective study from a tertiary care centre in North India.

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·2026

Same author

Efficacy of Early Exposure Medical Programs for Underrepresented Students: A Systematic Review.

Cureus·2026

Same author

Efficacy and Safety of Paclitaxel Plus Ramucirumab as Second-Line Therapy in Advanced Gastric Cancer: A Retro-Prospective Single-Centre Study.

The Gulf journal of oncology·2026

Same author

Real world experience with cyclin dependent kinase inhibitors in metastatic breast cancer in India.

PloS one·2026

Same author

Entropy-based multi-criteria decision optimization of dimpled solar air heater duct using WASPAS and MAIRCA models.

Scientific reports·2026

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Hepatic osteodystrophy.

Varun Goel¹, Premashis Kar

¹Department of Medicine, Maulana Azad Medical College, B.L.Taneja Block, New Delhi-India.

Tropical Gastroenterology : Official Journal of the Digestive Diseases Foundation

|September 25, 2010

Summary

This summary is machine-generated.

Hepatic Osteodystrophy (HO) is a bone disease in chronic liver disease patients. Early diagnosis and management, including Vitamin D, calcium, and bisphosphonates, improve outcomes.

Related Experiment Videos

Last Updated: Jun 8, 2026

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Area of Science:

Hepatology
Endocrinology
Bone Metabolism

Background:

Hepatic Osteodystrophy (HO) is a metabolic bone disease complicating chronic liver disease (CLD).
It encompasses osteoporosis and osteomalacia, affecting patients with cholestatic and non-cholestatic liver conditions.
HO significantly impacts patient morbidity, quality of life, and mortality due to fractures.

Purpose of the Study:

To review the significance, causes, diagnosis, and treatment of Hepatic Osteodystrophy.
To highlight recent advances and recommendations for managing this complication of CLD.
To emphasize the importance of early detection and prevention in advanced liver disease.

Main Methods:

Literature review focusing on Hepatic Osteodystrophy in chronic liver disease.
Analysis of diagnostic methods including bone mineral density and laboratory tests.
Evaluation of current and emerging therapeutic strategies.

Main Results:

HO is an under-recognized complication of CLD with multifactorial etiology.
Bone mineral density measurement is key for assessing osteopenia severity.
Newer diagnostic tools enhance HO detection.

Conclusions:

Vitamin D repletion, calcium supplementation, and bisphosphonates show promise for HO treatment.
Individualized management involves assessing risk factors, bone mass measurement, and tailored therapies.
Proactive management is crucial to prevent severe bone disease and improve prognosis in CLD patients.